Hims & Hers stock rises 14% as FDA schedules peptide compounding review [Yahoo! Finance]
Hims & Hers Health, Inc. Class A (HIMS)
Company Research
Source: Yahoo! Finance
Hims & Hers Health stock rose 13.7%, with premarket trading adding another 9.6% the next morning, MarketWatch reported. The FDA peptide review will cover BPC-157, KPV, TB-500, MOTs-C, Emideltide, Semax, and Epitalon, with recommendations non-binding. Hims & Hers said peptides are a target category, and its chief medical officer called the FDA's clarity an avenue toward trusted channels. In 2023 the FDA removed 19 peptides over safety risks; supporters seek broader access while critics warn of weak evidence and threats to drug standards.
Show less
Read more
Impact Snapshot
Event Time:
HIMS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
HIMS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
HIMS alerts
High impacting Hims & Hers Health, Inc. Class A news events
Weekly update
A roundup of the hottest topics
HIMS
News
- Bronstein, Gewirtz & Grossman, LLC Encourages Hims & Hers Health, Inc. (HIMS) Investors to Inquire about Securities InvestigationACCESS Newswire
- Stock Market Today, April 21: Hims & Hers Health Drops as Amazon Unveils Competing Weight Loss Program [Yahoo! Finance]Yahoo! Finance
- Stock Market Today, April 21: Hims & Hers Health Drops as Amazon Unveils Competing Weight Loss Program [Globe and Mail, The (Toronto, Canada)]Globe and Mail, The
- Amazon launches GLP-1 weight loss program, promising ‘fast, convenient' access [CNBC]CNBC
- Is It Time To Reassess Hims & Hers Health (HIMS) After The Recent Share Price Surge [Yahoo! Finance]Yahoo! Finance
HIMS
Earnings
- 2/23/26 - Beat
HIMS
Sec Filings
- 4/22/26 - Form 4
- 4/22/26 - Form 4
- 4/20/26 - Form 4
- HIMS's page on the SEC website